Information Provided By:
Fly News Breaks for June 7, 2016
RXII
Jun 7, 2016 | 07:06 EDT
H.C. Wainwright analyst Carol Ann Werther assumed coverage of RXi Pharmaceuticals with a Buy rating and $3.50 price target.
News For RXII From the Last 2 Days
There are no results for your query RXII